The purpose of the Scientific Core is to make available various transgenic and knockout mutants, primary cell cultures, general molecular biological techniques, biochemical assays, and morphological and histological methods to the four projects of the program. The availability of these services will allow investigators to conduct their studies with consistency in quality control of various methods and assays in a way that would not be possible for individual projects to achieve. One particular strength of this Scientific Core is that all the project leaders are actively participating in the execution of the experiments and provide their own expertise to others during monthly research seminars meetings. For example, Dr. Chan (Core Leader) will provide his expertise in the use of superoxide dismutase transgenic and knockout mutant mice as well as oxygen radicals-related biochemistry and molecular biology. Dr. Sharp will provide his expertise in gene expression (in situ hybridization and immunocytochemistry), DG autoradiography and [14C iodoantipyrine autoradiography for cerebral blood flow. Dr. Noble will offer her expertise in morphological assessments (both light and ultrastructure) of neuronal injury. Dr. Swanson will offer his expertise in HPLC measurements of .OH radicals and H2O2 and quantitative measurements of infarct volume using imaging analysis. In addition, Dr. Sylvia Chen, the coordinator of the Scientific Core, will provide her expertise in molecular analysis of gene expression (PCR, RT-PCR), primary cell culture and various biochemical assays. Thus, this Scientific Core provides an unique vehicle for various projects to achieve their research goals with a unified methodology and expertise that will complement one another.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
2P50NS014543-19
Application #
5215086
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Voloboueva, Ludmila A; Emery, John F; Sun, Xiaoyun et al. (2013) Inflammatory response of microglial BV-2 cells includes a glycolytic shift and is modulated by mitochondrial glucose-regulated protein 75/mortalin. FEBS Lett 587:756-62
Kim, Jong Youl; Kim, Nuri; Yenari, Midori A et al. (2013) Hypothermia and pharmacological regimens that prevent overexpression and overactivity of the extracellular calcium-sensing receptor protect neurons against traumatic brain injury. J Neurotrauma 30:1170-6
Sakata, Hiroyuki; Niizuma, Kuniyasu; Wakai, Takuma et al. (2012) Neural stem cells genetically modified to overexpress cu/zn-superoxide dismutase enhance amelioration of ischemic stroke in mice. Stroke 43:2423-9
Tang, Xian Nan; Cairns, Belinda; Kim, Jong Youl et al. (2012) NADPH oxidase in stroke and cerebrovascular disease. Neurol Res 34:338-45
Cairns, Belinda; Kim, Jong Youl; Tang, Xian Nan et al. (2012) NOX inhibitors as a therapeutic strategy for stroke and neurodegenerative disease. Curr Drug Targets 13:199-206
Voloboueva, Ludmila A; Giffard, Rona G (2011) Inflammation, mitochondria, and the inhibition of adult neurogenesis. J Neurosci Res 89:1989-96
Tang, Xian N; Zheng, Zhen; Giffard, Rona G et al. (2011) Significance of marrow-derived nicotinamide adenine dinucleotide phosphate oxidase in experimental ischemic stroke. Ann Neurol 70:606-15
Chen, Hai; Kim, Gab Seok; Okami, Nobuya et al. (2011) NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiol Dis 42:341-8
Yoshioka, Hideyuki; Niizuma, Kuniyasu; Katsu, Masataka et al. (2011) NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. J Cereb Blood Flow Metab 31:868-80
Xiong, Xiaoxing; Barreto, George E; Xu, Lijun et al. (2011) Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia. Stroke 42:2026-32

Showing the most recent 10 out of 103 publications